Mostrar el registro sencillo del ítem

Modulation of the activity of sp transcription factors by mithramycin analogues as a new strategy for treatment of metastatic prostate cancer

dc.contributor.authorMalek, A.
dc.contributor.authorNúñez González, Luz Elena 
dc.contributor.authorMagistri, M.
dc.contributor.authorBrambilla, L.
dc.contributor.authorJovic, S.
dc.contributor.authorCarbone, G. M.
dc.contributor.authorMorís Varas, Francisco
dc.contributor.authorCatapano, C. V.
dc.date.accessioned2017-03-29T05:59:57Z
dc.date.available2017-03-29T05:59:57Z
dc.date.issued2012
dc.identifier.citationPLoS ONE, 7(4) (2012); doi:10.1371/journal.pone.0035130
dc.identifier.issn1932-6203
dc.identifier.urihttp://hdl.handle.net/10651/41514
dc.description.sponsorshipThis work was supported by the Fondazione Ticinese per la Ricerca sul Cancro, Swiss National Science Foundation and Swiss Cancer League to CVC and GMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript
dc.language.isoeng
dc.relation.ispartofPLoS ONE
dc.rights© 2012 Malek et al.
dc.rightsCC Reconocimiento - No comercial - Sin obras derivadas 4.0 Internacional
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScopus
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84859868832&doi=10.1371%2fjournal.pone.0035130&partnerID=40&md5=1f79d90697c5496b0bfe429c2c433489
dc.titleModulation of the activity of sp transcription factors by mithramycin analogues as a new strategy for treatment of metastatic prostate cancereng
dc.typejournal article
dc.identifier.doi10.1371/journal.pone.0035130
dc.relation.publisherversionhttp://dx.doi.org/10.1371/journal.pone.0035130
dc.rights.accessRightsopen access


Ficheros en el ítem

untranslated

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

© 2012 Malek et al.
Este ítem está sujeto a una licencia Creative Commons